As of 9:58:02 AM EST. Market Open. GAITHERSBURG, Md., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company ...
Is Palantir (PLTR) stock a buy or sale amid a series of share sales by ARK ETFs managed by famed hedge fund manager Cathie ...
Barchart on MSN16h
Is Palantir Stock Headed for a Steeper Fall After a 20% Drop?Palantir (PLTR) was one of the top performers in 2024, with its stock soaring by an impressive 340.5% over the year. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback